The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA??Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 31 (5) , 273-277
- https://doi.org/10.1097/01.olq.0000124611.73009.d5
Abstract
The Gen-Probe APTIMA Combo 2 (AC2) assay is a second-generation transcription-mediated amplification assay for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). The goal of this study was to evaluate AC2 performance of endocervical (cx) swabs for the detection of CT and NG using either a specimen or an infected patient standard. In a multicenter clinical study, we compared AC2 with Abbott's ligase chain reaction (LCR) and Roche's polymerase chain reaction (PCR; Amplicor or COBAS) for CT, and we compared AC2 with Abbott's LCR and culture for NG. A total of 1569 females were enrolled in the study; we collected cx and first-catch urine (FCU) specimens. CT prevalence was 13.3% for cx specimens and 13.7% for FCU specimens. NG prevalence was 8.7% and 7.9% for cx and FCU specimens, respectively. When based only on cx specimens, AC2, LCR, and PCR sensitivities for CT were 99.4%, 95.6%, and 95.6%, respectively. However, cx sensitivity for CT was reduced to 92.1%, 86.6%, and 87.1% for each respective assay when based on both cx and FCU specimen results (infected patient standard). NG sensitivities for AC2, LCR, and culture based solely on cx specimen results were 99.2%, 96.1%, and 85.9%, respectively. Based on infected patient standard, the sensitivities of each respective assay were 98.5%, 93.9%, and 84.0%. The infected patient standard reduces the sensitivity of the endocervical evaluation because some infected patients are positive only with FCU. The reduction in sensitivity is greater when testing for CT. Specificities improved slightly, because some unique cx positives, initially classified as false-positive were confirmed by a positive FCU result. Sensitivity of AC2 was higher than LCR, PCR, and culture. Specificity was slightly lower, but discrepant analysis (using alternate TMA targets) of apparent AC2 false-positives showed that 75% to 80% were true-positives.Keywords
This publication has 32 references indexed in Scilit:
- Specimen Processing and Concentration of Chlamydia trachomatis Added Can Influence False-Negative Rates in the LCx Assay but Not in the APTIMA Combo 2 Assay When Testing for InhibitorsJournal of Clinical Microbiology, 2003
- Performance of the APTIMA Combo 2 Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Endocervical Swab SpecimensJournal of Clinical Microbiology, 2003
- Head-to-Head Multicenter Comparison of DNA Probe and Nucleic Acid Amplification Tests for Chlamydia trachomatis Infection in Women Performed with an Improved Reference StandardJournal of Clinical Microbiology, 2002
- Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral SwabsJournal of Clinical Microbiology, 2001
- Discrepant analysis and screening for Chlamydia trachomatisThe Lancet, 1998
- BIAS IN THE EVALUATION OF DNA-AMPLIFICATION TESTS FOR DETECTINGCHLAMYDIA TRACHOMATISStatistics in Medicine, 1997
- Noninvasive Tests for Diagnosis of Chlamydia trachomatis Infection: Application of Ligase Chain Reaction to First-Catch Urine Specimens of WomenThe Journal of Infectious Diseases, 1995
- Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urineThe Lancet, 1995
- Evaluation of syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimensDiagnostic Microbiology and Infectious Disease, 1992
- Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infectionJournal of Clinical Microbiology, 1986